The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States

Assaf Moore; Robert B. Den; Noa Gordon; Michal Sarfaty; Yulia Kundel; Baruch Brenner; Daniel A. Goldstein

doi:10.1016/j.clcc.2019.05.005

The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States

Assaf Moore, Robert B. Den, Noa Gordon, Michal Sarfaty, Yulia Kundel, Baruch Brenner, Daniel A. Goldstein

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

We performed a population-based analysis of the total annual cost of various radiotherapy regimens for rectal cancer in the United States. The target population was estimated using the Surveillance, Epidemiology, and End Results database and radiotherapy costs by the Hospital Outpatient Prospective Payment System. Short-course radiotherapy may have the potential to save US $106 to 232 million annually compared with long-course chemoradiotherapy, likely without impacting outcomes. Intensity-modulated radiotherapy increases the cost of treatment by 34% and 50% for short-course and long-course chemoradiotherapy, respectively.

Original language	English
Pages (from-to)	209-217
Number of pages	9
Journal	Clinical Colorectal Cancer
Volume	18
Issue number	3
DOIs	https://doi.org/10.1016/j.clcc.2019.05.005
State	Published - 1 Sep 2019
Externally published	Yes

Keywords

Chemoradiation
Hypofractionation
Intensity-modulated radiotherapy
Radiotherapy
Short-course radiotherapy

ASJC Scopus subject areas

Oncology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clcc.2019.05.005

Cite this

@article{6c5dd22f5c3b43a6a5662beb879323d4,

title = "The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States",

abstract = "We performed a population-based analysis of the total annual cost of various radiotherapy regimens for rectal cancer in the United States. The target population was estimated using the Surveillance, Epidemiology, and End Results database and radiotherapy costs by the Hospital Outpatient Prospective Payment System. Short-course radiotherapy may have the potential to save US $106 to 232 million annually compared with long-course chemoradiotherapy, likely without impacting outcomes. Intensity-modulated radiotherapy increases the cost of treatment by 34% and 50% for short-course and long-course chemoradiotherapy, respectively.",

keywords = "Chemoradiation, Hypofractionation, Intensity-modulated radiotherapy, Radiotherapy, Short-course radiotherapy",

author = "Assaf Moore and Den, {Robert B.} and Noa Gordon and Michal Sarfaty and Yulia Kundel and Baruch Brenner and Goldstein, {Daniel A.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = sep,

day = "1",

doi = "10.1016/j.clcc.2019.05.005",

language = "English",

volume = "18",

pages = "209--217",

journal = "Clinical Colorectal Cancer",

issn = "1533-0028",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States

AU - Moore, Assaf

AU - Den, Robert B.

AU - Gordon, Noa

AU - Sarfaty, Michal

AU - Kundel, Yulia

AU - Brenner, Baruch

AU - Goldstein, Daniel A.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - We performed a population-based analysis of the total annual cost of various radiotherapy regimens for rectal cancer in the United States. The target population was estimated using the Surveillance, Epidemiology, and End Results database and radiotherapy costs by the Hospital Outpatient Prospective Payment System. Short-course radiotherapy may have the potential to save US $106 to 232 million annually compared with long-course chemoradiotherapy, likely without impacting outcomes. Intensity-modulated radiotherapy increases the cost of treatment by 34% and 50% for short-course and long-course chemoradiotherapy, respectively.

AB - We performed a population-based analysis of the total annual cost of various radiotherapy regimens for rectal cancer in the United States. The target population was estimated using the Surveillance, Epidemiology, and End Results database and radiotherapy costs by the Hospital Outpatient Prospective Payment System. Short-course radiotherapy may have the potential to save US $106 to 232 million annually compared with long-course chemoradiotherapy, likely without impacting outcomes. Intensity-modulated radiotherapy increases the cost of treatment by 34% and 50% for short-course and long-course chemoradiotherapy, respectively.

KW - Chemoradiation

KW - Hypofractionation

KW - Intensity-modulated radiotherapy

KW - Radiotherapy

KW - Short-course radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85067873568&partnerID=8YFLogxK

U2 - 10.1016/j.clcc.2019.05.005

DO - 10.1016/j.clcc.2019.05.005

M3 - Article

C2 - 31255477

AN - SCOPUS:85067873568

SN - 1533-0028

VL - 18

SP - 209

EP - 217

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

IS - 3

ER -

The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this